10.1038/nature09410 Nature 91 LeeJ
What does nitric oxide (NO) pathway mean, and why is it mentioned
It has shown significant promise as an effective intervention against type 2 diabetes (T2D) and excessive body weight, resulting in the United States Food and Drug Administration (FDA) approving its use against both conditions in May 2022 for T2D and November 2023 for obesity
What is the maximum dose available, and does it match the FDA-approved therapeutic range
For product specifics and adverse effects (e.g., injection-site reactions, rare hypersensitivity), consult Cyanocobalamin injection and set realistic expectations
Complete your online consultation You fill out a brief medical intake about your goals, symptoms, and health history